Article

UV toxicity may be culprit in post-LASIK dry eye

Hypoesthesia is not the origin of post-LASIK punctuate epithelial keratopathy or the so-called dry eye syndrome. Rather, these sequelae may represent a phototoxic effect of treatment with the ultraviolet excimer laser, said Carmen Barraquer-Coll, MD.

Hypoesthesia is not the origin of post-LASIK punctuate epithelial keratopathy or the so-calleddry eye syndrome. Rather, these sequelae may represent a phototoxic effect of treatment withthe ultraviolet excimer laser, said Carmen Barraquer-Coll, MD.

"In our surgical and clinical experience we have never seen dry eye in recipients ofpenetrating or lamellar grafts or in eyes that have undergone freezing keratomileusis,epikeratophakia, planar keratomileusis, or in situ keratomileusis with and without a hinge. Norhave we found any publications on the so-called dry eye syndrome after these procedures,"observed Dr. Barraquer-Coll, head, refractive surgery department, Barraquer Clinic, Bogota,Colombia.

"Like LASIK, these are all corneal surgeries associated with nerve sectioning or tissuedenervation," Dr. Barraquer-Coll said. "Use of the excimer laser is the most obvious answer to the question of what is thedifference between LASIK and these corneal surgeries."

Dr. Barraquer-Coll hypothesized that every pulse of the laser produces an equal area ofcollateral damage. In addition, through a reaction with ambient oxygen, there is the potentialfor release of ozone.

This concept is being investigated in a prospective open label clinical trial where eyes wereallocated to undergo LASIK with a standard technique or a protected technique involvingcovering of the limbus, bulbar conjunctiva, and stromal side of the flap. A preliminaryanalysis was performed using data from a total of 143 eyes. The two surgical groups were nearlyequally represented, and they were similar with respect to gender, age, preoperative SchirmerII and tear breakup time results, defocus, and total ablation depth.

In logistic regression analysis, eyes operated on with the protected technique had anapproximately 70% lower risk of dry eye syndrome postoperatively. Females had a threefoldgreater risk than males.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.